Price Momentum and Recent Market Performance
Trading at ₹9,596.75 as of 24 Sep 2026, Divis Laboratories Ltd has gained 2.70% on the day, closing well above its previous close of ₹9,344.00. The stock’s intraday range fluctuated between ₹9,305.95 and ₹9,621.25, reflecting healthy volatility within a bullish context. Notably, the stock remains close to its 52-week high of ₹10,000.00, a level that underscores its resilience in the Pharmaceuticals & Biotechnology sector.
Comparatively, Divis Laboratories has outperformed the broader market benchmark, the Sensex, across multiple time horizons. Over the past week, the stock returned 4.32% against the Sensex’s modest 0.66%. The one-month return is particularly striking at 12.24%, while the Sensex declined by 3.50% during the same period. Year-to-date, Divis Laboratories has surged 50.07%, contrasting sharply with the Sensex’s 12.19% loss. This outperformance extends over longer durations as well, with a 58.60% gain over one year and an impressive 619.50% over ten years, highlighting the stock’s sustained growth trajectory.
Technical Indicator Analysis: MACD, RSI, and Moving Averages
The Moving Average Convergence Divergence (MACD) indicator presents a bullish outlook on both weekly and monthly charts, signalling upward momentum and potential continuation of the rally. The MACD’s positive crossover and divergence from the signal line reinforce the stock’s strength in the medium to long term.
Conversely, the Relative Strength Index (RSI) reveals a more cautious picture. Both weekly and monthly RSI readings are bearish, suggesting that the stock may be experiencing short-term overbought conditions or a temporary momentum slowdown. This divergence between MACD and RSI indicates a complex momentum environment where price strength is supported by trend-following indicators but tempered by oscillators signalling potential pullbacks or consolidation phases.
Daily moving averages further bolster the bullish case. The stock’s price remains comfortably above its key daily moving averages, which have turned upward, confirming a positive short-term trend. This alignment of daily moving averages with the MACD’s bullish signals provides a strong technical foundation for continued price appreciation.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Bollinger Bands and KST: Confirming Volatility and Momentum
Bollinger Bands on both weekly and monthly timeframes are signalling bullish momentum. The stock price is trading near the upper band, indicating strong buying interest and potential continuation of the upward trend. This suggests that volatility is expanding in favour of the bulls, which often precedes further price gains.
The Know Sure Thing (KST) indicator presents a mixed view. Weekly KST remains bullish, supporting the short-term momentum, while the monthly KST is mildly bearish, hinting at some caution over the longer horizon. This divergence suggests that while the immediate trend is positive, investors should remain vigilant for potential shifts in momentum over the coming months.
Volume and Dow Theory Signals
On-Balance Volume (OBV) analysis shows a mildly bearish signal on the weekly chart but turns bullish on the monthly scale. This indicates that while recent trading volumes may have been somewhat subdued or mixed, the longer-term accumulation trend remains positive, supporting the stock’s price strength.
Dow Theory assessments add further nuance. The weekly Dow Theory signal is mildly bearish, reflecting short-term corrective pressures or consolidation phases. However, the monthly Dow Theory remains bullish, reinforcing the stock’s longer-term uptrend and underlying strength in the Pharmaceuticals & Biotechnology sector.
Mojo Score and Rating Update
MarketsMOJO has recently downgraded Divis Laboratories Ltd from a Buy to a Hold rating as of 22 Sep 2026, reflecting the mixed technical signals and the need for cautious optimism. The current Mojo Score stands at 64.0, consistent with a Hold grade, signalling that while the stock exhibits strong fundamentals and technical momentum, some indicators advise prudence. This rating adjustment aligns with the technical trend shift from mildly bullish to bullish, tempered by oscillators and volume-based signals.
As a large-cap stock within the Pharmaceuticals & Biotechnology sector, Divis Laboratories continues to command investor attention due to its robust price performance and sectoral leadership. The recent technical developments suggest that while the stock is well-positioned for further gains, investors should monitor momentum oscillators and volume trends closely for signs of potential reversals or consolidation.
Divis Laboratories Ltd or something better? Our SwitchER feature analyzes this large-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Divis Laboratories Ltd’s technical landscape is characterised by a strong bullish momentum supported by MACD, moving averages, and Bollinger Bands, while tempered by bearish RSI and mixed volume indicators. This combination suggests that the stock is in a phase of robust price appreciation but may encounter intermittent pullbacks or consolidation periods.
Investors should consider the stock’s impressive returns relative to the Sensex, with a 1-year gain of 58.60% and a decade-long return exceeding 600%, underscoring its long-term growth credentials. However, the recent downgrade to Hold by MarketsMOJO reflects the need for vigilance amid evolving technical signals.
Overall, Divis Laboratories remains a compelling large-cap player in the Pharmaceuticals & Biotechnology sector, with technical parameters indicating a bullish trend that is likely to persist, provided the stock maintains support above key moving averages and the MACD continues to signal strength. Monitoring RSI and volume trends will be crucial for timing entries and exits in the near term.
Summary of Key Technical Metrics:
- Current Price: ₹9,596.75 (up 2.70% on 24 Sep 2026)
- 52-Week Range: ₹5,637.50 - ₹10,000.00
- MACD: Weekly and Monthly - Bullish
- RSI: Weekly and Monthly - Bearish
- Bollinger Bands: Weekly and Monthly - Bullish
- Moving Averages (Daily): Bullish
- KST: Weekly - Bullish; Monthly - Mildly Bearish
- Dow Theory: Weekly - Mildly Bearish; Monthly - Bullish
- OBV: Weekly - Mildly Bearish; Monthly - Bullish
- Mojo Score: 64.0 (Hold), downgraded from Buy on 22 Sep 2026
In conclusion, Divis Laboratories Ltd’s technical parameters reflect a stock in transition towards stronger bullish momentum, albeit with cautionary signals from momentum oscillators and volume indicators. Investors should weigh these factors carefully within their portfolio strategies, balancing the stock’s strong historical performance against the current mixed technical signals.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
